Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from AASERT study

MLA

Stellbrink, Hans-Jurgen, et al. “Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from AASERT Study.” Clinical Infectious Diseases, vol. 51, no. 8, Oct. 2010, p. 963. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.240832200&authtype=sso&custid=ns315887.

APA

Stellbrink, H.-J., Orkin, C., Arribas, J. R., Compston, J., Gerstoft, J., Van Wijngaerden, E., Lazzarin, A., Rizzardini, G., Sprenger, H. G., Lambert, J., Sture, G., Leather, D., Hughes, S., Zucchi, P., & Pearce, H. (2010). Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from AASERT study. Clinical Infectious Diseases, 51(8), 963.

Chicago

Stellbrink, Hans-Jurgen, Chloe Orkin, Jose Ramon Arribas, Juiet Compston, Jan Gerstoft, Eric Van Wijngaerden, Adriano Lazzarin, et al. 2010. “Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from AASERT Study.” Clinical Infectious Diseases 51 (8): 963. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.240832200&authtype=sso&custid=ns315887.